Marker Therapeutics, Inc.
MRKRNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $20.67M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.84$2.46
- Volume (live)
- -
- Avg. volume (3M)
- 136.32K
Marker Therapeutics (MRKR) Stock Price & Financial Analysis
Marker Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.07 - $1.17 |
|---|---|
| 52-Week High | $2.46 |
| 52-Week Low | $0.84 |
| Open | $1.17 |
| Volume (last close) | 91.56K |
| Average Volume (3M) | 136.32K |
| Revenue (TTM) | 1.23M |
|---|---|
| Net Income (TTM) | -8.71M |
| Free Cash Flow (TTM) | -9.76M |
| EPS (TTM) | −$0.49 |
| Profit Margin | -706.23% |
| Operating Margin | -813.67% |
| Return on Equity (ROE) | -71.57% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 20.67M |
|---|---|
| Shares Outstanding | 19.31M |
| Price to Sales (P/S) | 16.76 |
| Price to Book (P/B) | 1.70 |
| EV/EBITDA | -1.04 |
| 50-Day MA | $1.17 |
|---|---|
| 200-Day MA | $1.40 |
| 1-Year Change | +7.58% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Marker Therapeutics at a Glance
As of the Oct 22, 2026 close, Marker Therapeutics (MRKR) has a market capitalization of $20.67M. The stock trades at 16.8× sales. Over the trailing twelve months it lost $8.71M on revenue of $1.23M and burned $9.76M of free cash flow. Revenue fell 65.3% year over year.
As of its latest reported balance sheet, it holds $11.33M in cash and securities against $0.00 of debt, a net cash position of $11.33M.
Marker Therapeutics does not currently pay a dividend.
The share price is up 7.6% over the past year. At $1.07 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $0.84 to $2.46, below its 200-day moving average of $1.40.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Marker Therapeutics
What is the current stock price for MRKR?
As of the Oct 22, 2026 close, MRKR stock trades at $1.07. The 52-week range is $0.84–$2.46, with a day range of $1.07–$1.17.
What is the P/E ratio for MRKR?
The P/E ratio (Price-to-Earnings) for MRKR is shown in the Key Statistics section. This valuation metric helps compare Marker Therapeutics, Inc. to industry peers.
Does MRKR pay dividends?
Marker Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MRKR?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for MRKR is Buy.
What is the market cap of MRKR?
As of the Oct 22, 2026 close, Marker Therapeutics's market capitalization is $20.7M, classifying it as a micro-cap company. Marker Therapeutics operates in the Healthcare sector within the Biotechnology industry.